COMMUNIQUÉS West-GlobeNewswire

Ionetix Announces Approval of Abbreviated New Drug Application for Gallium Ga-68 Gozetotide (PSMA-11)
26/05/2026
Leading particle accelerator company expands portfolio of positron emission tomography diagnostics LANSING, Mich., May 26, 2026 (GLOBE NEWSWIRE) -- Ionetix Corporation (“Ionetix”), a leading particle accelerator company [...]
Resolutions from Zealand Pharma's Extraordinary General Meeting 2026
26/05/2026
Company announcement – No. 17 / 2026 Resolutions from Zealand Pharma's Extraordinary General Meeting 2026 Copenhagen, Denmark, May 26, 2026 - Zealand Pharma A/S ("Zealand Pharma" or the “Company”) (Nasdaq: ZEAL) (CVR-no [...]
Novo Nordisk A/S - share repurchase programme
26/05/2026
Bagsværd, Denmark, 26 May 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) [...]
Visory Health Announces Two Senior Executives’ Promotions Amid Rapid Growth
26/05/2026
With more than 25 years of combined experience in enterprise expansion, security and innovation, the new Chief Growth Officer and Chief Technology Officer signal continued momentum as Visory Health builds on its [...]
BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data
26/05/2026
Fully enrolled, randomized, double-blind, sham-controlled Phase 2 study has completed treatment administration in 99 patients; Company continues Phase 3 readiness activities following FDA Type B meeting alignment [...]
Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies
26/05/2026
ALN1003 demonstrated consistent, favorable effects across key drivers of metabolic disease, including reductions in body weight and fat mass, improved insulin sensitivity, enhanced adipose function, and improved liver [...]
Zealand Pharma - Transactions related to share buy-back program (week 21, 2026)
26/05/2026
Company announcement No. 18 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 21, 2026) Copenhagen, Denmark, May 26, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL [...]
SBC Medical will participate in several upcoming investor conferences in May and June 2026
26/05/2026
IRVINE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range [...]
Comprehensive Healthcare launches Comprehensive Mobile Unit in Ellensburg
26/05/2026
New mobile unit expands opioid treatment access to Kittitas County YAKIMA, Wash., May 26, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare is bringing life-saving opioid treatment to Kittitas County with the launch of [...]
IBA – ACQUISITION D’ACTIONS PROPRES
26/05/2026
Louvain-la-Neuve, Belgique, 26 mai 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique [...]
IBA – ACQUISITION OF OWN SHARES
26/05/2026
Louvain-la-Neuve, Belgium, May 26 th , 2026 – 6 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
Affordable GLP-1 Telehealth Platform Ozari Health Announces New Industry-Wide Research Analysis on GLP-1 Pricing Data
26/05/2026
Ozari Health publishes first-of-its-kind pricing analysis to help patients understand the real cost of GLP-1 medications. New York, NY, May 26, 2026 (GLOBE NEWSWIRE) -- Ozari Health , the New York-based telehealth [...]
TG Therapeutics Announces Data Presentations for BRIUMVI® at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting
26/05/2026
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy) data in adults with relapsing forms of [...]
Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
26/05/2026
- Submission for Accelerated Approval based on dystrophin as a surrogate endpoint - - In the registrational expansion cohort of the DELIVER trial, treatment with z-rostudirsen resulted in a robust and statistically [...]
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
26/05/2026
Independent DSMB has identified no safety concerns, to date, and recommends continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor Sixth consecutive positive DSMB recommendation [...]
Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases
26/05/2026
Plus and Harvard analysis shows CNSide enables early diagnosis and better clinical decision-making reducing healthcare costs by 40% Presentation receives blue-ribbon recognition at the ISPOR Annual Meeting, the premier [...]
J-Star Holding Subsidiary Receives Central Bank of Taiwan Authorization to Initiate $60 Million Sovereign-Backed Financing Framework through Designated Banks for U.S. Solid-State Battery Expansion ($122.5 Million Project)
26/05/2026
Funding framework supports development of a US$122.5 million advanced battery manufacturing facility in Baytown, Texas under YMA(TX) INC. TAICHUNG CITY, Taiwan, May 26, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd [...]
Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations
26/05/2026
Company Reports Record Early Production Results, Exceeding Yield Targets by 20% ANN ARBOR, Mich., May 26, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig' [...]
Brain Cancer Canada Invests $50,000 in Promising Immunotherapy Breakthrough Targeting One of the Most Aggressive Brain Tumours
26/05/2026
TORONTO, May 26, 2026 (GLOBE NEWSWIRE) -- Brain Cancer Canada (BCC), Canada’s only 100% volunteer-driven charity dedicated exclusively to funding brain cancer research nationwide is proud to award $50,000 to an exciting [...]

Pages